penicillin g has been researched along with Community Acquired Infection in 23 studies
Penicillin G: A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.
benzylpenicillin : A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Norwegian guideline recommendations on first-line empirical antibiotic prescribing in hospitalised patients with community-acquired pneumonia (CAP) are penicillin G/V in monotherapy, or penicillin G in combination with gentamicin (or cefotaxime) in severely ill patients." | 7.96 | Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study. ( Garcia, BH; Høgli, JU; Skogen, V; Småbrekke, L; Svendsen, K, 2020) |
| "We report a case of community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci (VRE) in a 79-year-old woman." | 7.74 | Community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci. ( Cheng, CK; Lee, TS; Tang, CW, 2007) |
| "Norwegian guideline recommendations on first-line empirical antibiotic prescribing in hospitalised patients with community-acquired pneumonia (CAP) are penicillin G/V in monotherapy, or penicillin G in combination with gentamicin (or cefotaxime) in severely ill patients." | 3.96 | Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study. ( Garcia, BH; Høgli, JU; Skogen, V; Småbrekke, L; Svendsen, K, 2020) |
| "We investigated the in vitro activity of AR-709, a novel diaminopyrimidine antibiotic currently in development for treatment of community-acquired upper and lower respiratory tract infections, against 151 Streptococcus pneumoniae strains from various European countries." | 3.74 | In vitro activity of AR-709 against Streptococcus pneumoniae. ( Jansen, WT; Milatovic, D; Verel, A; Verhoef, J, 2008) |
| "We report a case of community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci (VRE) in a 79-year-old woman." | 3.74 | Community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci. ( Cheng, CK; Lee, TS; Tang, CW, 2007) |
| "Penicillin G successfully treated 82% (126/154) of the study group and improvement was marked on the first day of treatment." | 1.37 | Outcome of children hospitalized with community-acquired pneumonia treated with aqueous penicillin G. ( Araújo, M; Nascimento-Carvalho, CM; Simbalista, R, 2011) |
| "Increasing prevalence in otitis and pneumonia in children and in community-acquired pneumonia in adults may lead to use of vancomycin as empirical therapy for these clinical situations." | 1.29 | Penicillin-resistant pneumococci--an emerging threat to successful therapy. ( McGowan, JE; Metchock, BG, 1995) |
| "To evaluate the bacteriology of early aspiration pneumonia using a protected specimen brush and quantitative culture techniques, and whether penicillin G is adequate as initial treatment pending culture results." | 1.29 | Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures. ( Brun, P; Coste, F; Darchy, B; Djedaïni, K; Dreyfuss, D; Lanore, JJ; Mier, L; Weber, P, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (34.78) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 5 (21.74) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Jansen, WT | 1 |
| Verel, A | 1 |
| Verhoef, J | 1 |
| Milatovic, D | 1 |
| Lawrence, L | 1 |
| Danese, P | 1 |
| DeVito, J | 1 |
| Franceschi, F | 1 |
| Sutcliffe, J | 1 |
| Høgli, JU | 1 |
| Garcia, BH | 1 |
| Svendsen, K | 1 |
| Skogen, V | 1 |
| Småbrekke, L | 1 |
| Thegerström, J | 1 |
| Månsson, V | 1 |
| Riesbeck, K | 1 |
| Resman, F | 1 |
| Brandão, A | 1 |
| Simbalista, R | 2 |
| Borges, IC | 1 |
| Andrade, DC | 1 |
| Araújo, M | 2 |
| Nascimento-Carvalho, CM | 2 |
| Lorgelly, PK | 1 |
| Atkinson, M | 2 |
| Lakhanpaul, M | 2 |
| Smyth, AR | 1 |
| Vyas, H | 2 |
| Weston, V | 2 |
| Stephenson, T | 2 |
| Korppi, M | 1 |
| Hoban, D | 1 |
| Waites, K | 1 |
| Felmingham, D | 1 |
| Cetinkaya, F | 1 |
| Gogremis, A | 1 |
| Kutluk, G | 1 |
| Tang, CW | 1 |
| Cheng, CK | 1 |
| Lee, TS | 1 |
| Smyth, A | 1 |
| Sithole, J | 1 |
| Owen, V | 1 |
| Halliday, K | 1 |
| Sammons, H | 1 |
| Crane, J | 1 |
| Guntupalli, N | 1 |
| Walton, L | 1 |
| Ninan, T | 1 |
| Morjaria, A | 1 |
| McGowan, JE | 1 |
| Metchock, BG | 1 |
| Bohte, R | 1 |
| van't Wout, JW | 1 |
| Lobatto, S | 1 |
| Blussé van Oud Alblas, A | 1 |
| Boekhout, M | 1 |
| Nauta, EH | 1 |
| Hermans, J | 1 |
| van den Broek, PJ | 1 |
| Pallares, R | 2 |
| Liñares, J | 2 |
| Vadillo, M | 1 |
| Cabellos, C | 1 |
| Manresa, F | 2 |
| Viladrich, PF | 1 |
| Martin, R | 1 |
| Gudiol, F | 2 |
| Gaillat, J | 1 |
| Bru, JP | 1 |
| Sedallian, A | 1 |
| Hamour, A | 1 |
| Bonnington, A | 1 |
| Wilkins, EG | 1 |
| Mier, L | 2 |
| Dreyfuss, D | 2 |
| Darchy, B | 1 |
| Lanore, JJ | 1 |
| Djedaïni, K | 1 |
| Weber, P | 1 |
| Brun, P | 1 |
| Coste, F | 1 |
| Léophonte, P | 1 |
| Sherer, Y | 1 |
| Bakshi, E | 1 |
| Rotman, P | 1 |
| Levy, Y | 1 |
| Shoenfeld, Y | 1 |
| Rosón, B | 1 |
| Carratalà, J | 1 |
| Tubau, F | 1 |
| Dorca, J | 1 |
| Dobbin, CJ | 1 |
| Duggan, CJ | 1 |
| Barnes, DJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Ceftriaxone Versus Chloramphenicol for Treatment of Severe Pneumonia in Children Aged Less Than Five Years at Mulago Hospital: A Randomized Controlled Trial[NCT00372541] | Phase 3 | 348 participants (Anticipated) | Interventional | 2006-09-30 | Completed | ||
| Assessing the Feasibility and Effectiveness of Introducing Pulse Oximetry in IMCI Services to Manage Acute Respiratory Infections at First Level Health Facilities of Bangladesh[NCT03750747] | 612 participants (Anticipated) | Interventional | 2018-12-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for penicillin g and Community Acquired Infection
| Article | Year |
|---|---|
Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis.
Topics: Administration, Oral; Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Hospitalized; Ch | 2010 |
Comparison of two antibiotic regimens in the empirical treatment of severe childhood pneumonia.
Topics: Ceftriaxone; Child, Hospitalized; Child, Preschool; Chloramphenicol; Community-Acquired Infections; | 2004 |
Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infec | 2007 |
Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia.
Topics: Administration, Oral; Adult; Aged; Azithromycin; Community-Acquired Infections; Erythromycin; Female | 1995 |
Penicillin G/ofloxacin versus erythromycin/amoxicillin-clavulanate in the treatment of severe community-acquired pneumonia.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Community | 1994 |
Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; | 2001 |
17 other studies available for penicillin g and Community Acquired Infection
| Article | Year |
|---|---|
In vitro activity of AR-709 against Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Europe; | 2008 |
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
Topics: Anti-Infective Agents; Bacteria; Community-Acquired Infections; Cross Infection; Enterococcus; Human | 2008 |
Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Community-Acquired Infections; Female; Guideline Adh | 2020 |
Benzylpenicillin versus wide-spectrum beta-lactam antibiotics as empirical treatment of Haemophilus influenzae-associated lower respiratory tract infections in adults; a retrospective propensity score-matched study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Child; | 2018 |
Retrospective analysis of the efficacies of two different regimens of aqueous penicillin G administered to children with pneumonia.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Drug Administration S | 2014 |
Outcome of children hospitalized with community-acquired pneumonia treated with aqueous penicillin G.
Topics: Anti-Bacterial Agents; Brazil; Child; Child, Preschool; Cohort Studies; Community-Acquired Infection | 2011 |
Diagnosis and treatment of community-acquired pneumonia in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Community-Acquired Infections; Finland; Humans; Lung; Pen | 2012 |
Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study.
Topics: Anti-Bacterial Agents; Canada; Community-Acquired Infections; Drug Resistance, Microbial; Erythromyc | 2003 |
Community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Drug Therapy, Combination; E | 2007 |
Penicillin-resistant pneumococci--an emerging threat to successful therapy.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Community-A | 1995 |
Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.
Topics: Adult; Aged; Bacteremia; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Community-Acquired Infec | 1995 |
Severe community acquired pneumonia associated with a desquamating rash due to group A beta-haemolytic streptococcus.
Topics: Community-Acquired Infections; Humans; Male; Middle Aged; Penicillin G; Pleural Effusion; Pneumonia, | 1994 |
Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures.
Topics: Adult; Age Factors; Aged; Asepsis; Bronchoscopes; Community-Acquired Infections; Comorbidity; Cross | 1993 |
[Management of community-acquired pneumopathies of adults in the city and at the hospital].
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalospo | 1998 |
Comparative clinical study of cefonicid, chloramphenicol, and penicillin in community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Blood Cell Count; Cefonicid; Chloramphenicol; Community-Acquired Infections; | 1998 |
The efficacy of an antibiotic protocol for community-acquired pneumonia.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Clinical Protocols; Commu | 2001 |
Aspiration pneumonia.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Community-Acquired Infections; Cross Infection; Humans; | 2001 |